A+ A-

 

The ban on sales of alcohol and tobacco to minors

 

The ban on sales of alcohol and tobacco to minors

Tendances n°87, OFDT, 4 p.
September 2013

The Hospital, Patients, Health and Territories (French) law of July 21, 2009 (the so-called «HPST law») established a ban on the sale of alcoholic beverages and tobacco products to all minors. The prior regulations had banned the sale of alcoholic beverages and tobacco to minors under the age of 16. By expanding the restrictions to minors aged 16-17, legislators hoped to provide a firm response to the risks related to recent trends in alcohol consumption («massive alcohol abuse») and tobacco smoking among adolescents. In addition, these legislative provisions fall within the scope of guidelines issued by the World Health Organisation (WHO), which recommends implementing validated public health strategies, including banning the sale of alcohol and tobacco to minors. The National Health Directorate (DGS) commissioned the French Monitoring Centre for Drugs and Drug Addiction (OFDT) to conduct an evaluation of how the ban on sales to minors was being implemented and what the impact of the ban was on prevalence and accessibility. To do this, the OFDT used several existing surveys and conducted two ad hoc studies. This issue of Tendances provides a summary of the key results of this assessment.

Authors:
Cristina Díaz Gómez, Aurélie Lermenier, Maitena Milhet

Download the PDF file (750 Ko)

 

 

 

 

 

 

 

Drugs in Europe


2023 EMCDDA European Drug Report

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.

  Statistical Bulletin 2023

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.